FOXO4-DRI Guide (2026)
Complete Guide & Evidence (2026)
Senolytic peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction. Anti-aging research compound.
Senolytic Mechanism: Clearing Zombie Cells
Senescent Cell Problem
Aging cells that stop dividing but refuse to die. Secrete pro-inflammatory SASP cytokines. Accumulate with age, causing tissue dysfunction
FOXO4-p53 Disruption
FOXO4 protein keeps senescent cells alive. FOXO4-DRI peptide blocks FOXO4-p53 interaction. p53 is freed to trigger apoptosis in senescent cells
Selective Clearance
Healthy cells have MDM2-regulated p53 (protected). Senescent cells lack MDM2 suppression. Specificity for senescent cell apoptosis
Why Senescent Cell Clearance Matters
Senescent cells increase dramatically from age 40 onward and can represent 15–20% of total cells in some aging tissues. Their SASP secretions drive chronic inflammation, impair stem cell niches, and a
Original Research Results
Naturally aged mice showed restored fitness, fur coat, and grip strength after FOXO4-DRI treatment.
IP injection dose used in the original 2017 Nature Medicine study in mice.
Dosing frequency used in the original mouse protocol and adapted for biohacking.
FOXO4-DRI Protocol Approaches
Critical note: No human clinical trials exist. FOXO4-DRI is purely investigational. The theoretical risk of off-target apoptosis in healthy cells makes physician oversight and careful monitoring essential. Track all biomarkers and subjective changes in the Shotlee app.
Senolytic Research Timeline
First demonstration that clearing senescent cells in mice prevents age-related tissue pathologies (Baker et al., Nature).
de Keizer/Hoeijmakers publish FOXO4-DRI in Nature Medicine — dramatic aging reversal in mice.
Dasatinib + Quercetin first senolytic combination enters human trials (Mayo Clinic).
FOXO4-DRI still has no human trials. Biohacker community self-experimenting with research-grade peptide.
Vital Protocol FAQs
What is FOXO4-DRI peptide?
FOXO4-DRI is a modified (D-retro inverso) peptide developed by researchers Peter de Keizer and Jan Hoeijmakers. It is designed to break the FOXO4-p53 interaction that keeps senescent (zombie) cells al
What is the FOXO4-DRI dosing protocol?
The original mouse study used 5 mg/kg by IP (intraperitoneal) injection 3 days per week for 10 days, then 3-day-per-week pulsed dosing for ongoing treatment. Human biohacking protocols typically use 1
What were the results in the original FOXO4-DRI mouse study?
The landmark 2017 Nature Medicine paper showed that FOXO4-DRI treatment in naturally aged mice restored fitness, fur density, and kidney function. Fast-aging (XPF-ERCC1) mice showed dramatic improveme
Is FOXO4-DRI safe for humans?
There are no human clinical trials for FOXO4-DRI. The key theoretical safety concern is off-target apoptosis in healthy cells, though the mechanism is designed to spare normal cells with intact p53-MD
Guide FAQs
Senolytic peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction. Anti-aging research compound.
Yes. Shotlee supports tracking Foxo4 Dri doses, side effects, and health metrics. It is free to use.
References
Track Your Foxo4 Dri Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
🚀 Use Shotlee for Free